Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Jazz Pharmaceuticals PLC    JAZZ   IE00B4Q5ZN47

JAZZ PHARMACEUTICALS PLC (JAZZ)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Business Summary
Logo Jazz Pharmaceuticals PLC
Operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry.

Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Dublin, Ireland.

Number of employees : 1 210 persons.
Sales per Businesses
20162017Delta
USD (in Million)%USD (in Million)%
Product1,47799.3%1,60198.9% +8.4%
Royalties and Contract Revenues10.710.7%17.291.1% +61.45%
Sales per Regions
20162017Delta
USD (in Million)%USD (in Million)%
United States1,35591.1%1,46390.4% +8.01%
Europe106.157.1%122.797.6% +15.68%
Other26.911.8%32.452% +20.59%
Managers
NameAgeSinceTitle
Bruce C. Cozadd, MBA542012Chairman & Chief Executive Officer
Daniel N. Swisher Jr., MBA552018President & Chief Operating Officer
Matthew P. Young, MBA482013Chief Financial Officer & Executive Vice President
Paul Treacy572014Senior Vice President-Technical Operations
Paul L. Berns512010Independent Director
Patrick G. Enright, MBA562012Independent Director
Seamus C. Mulligan572012Independent Director
Ken W. O'Keefe, MBA512012Independent Director
Rick E. Winningham, MBA582012Lead Independent Director
Catherine Angell Sohn, PhD652012Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 60,286,730 58,484,274 97.0% 0 0.0% 97.0%
Shareholders
NameEquities%
Putnam Investment Management LLC 7,181,876 12.0%
Fidelity Management & Research Co. 5,801,628 9.67%
The Vanguard Group, Inc. 4,745,950 7.91%
BlackRock Fund Advisors 2,066,461 3.44%
Senator Investment Group LP 1,498,295 2.50%
TIAA-CREF Investment Management LLC 1,241,452 2.07%
Cadian Capital Management LP 1,211,589 2.02%
Westfield Capital Management Co. LP 1,203,405 2.01%
Waddell & Reed Investment Management Co. 1,189,477 1.98%
Partner Fund Management LP 1,151,065 1.92%
Company contact information
Jazz Pharmaceuticals Plc
Waterloo Exchange
Waterloo Road
Dublin 4

Phone : +353.1.634.7800
Fax : +353.1.634.7850
Web : www.jazzpharma.com
Connections : Jazz Pharmaceuticals PLC
Sohn Health Strategies LLC
Aptinyx, Inc.
Beecken Petty O'Keefe & Co. LP
Adapt Pharma Ltd.
Pharmaceutical Research & Manufacturers of America
Theravance Biopharma US, Inc.
Ariel Pharmaceuticals, Inc.
The Okizu Foundation
Dohmen Life Science Services LLC
Circ Pharma Ltd.
Jazz Pharmaceuticals, Inc.
Orbus Therapeutics, Inc.
The Nueva School
Longitude Capital Management Co. LLC
Rubius Therapeutics, Inc.
InfaCare Pharmaceutical Corp.
Raven Biotechnologies, Inc.
World Affairs Council of Philadelphia
SutroVax, Inc.
University of the Sciences in Philadelphia
© 2018 People , Fundamentals and Ownership